BioProcess International (BPI) 2025 showcased significant advancements in bioprocessing, drawing attention from industry leaders and innovators alike. Attended by GEN editor in chief John Sterling and deputy editor Julianna LeMieux, PhD, the event served as a platform for discussions on emerging technologies and trends shaping the biopharmaceutical landscape. This year, GEN also hosted its inaugural client appreciation reception, highlighting the importance of collaboration within the sector.
The conversations at BPI 2025 underscored the growing emphasis on efficiency and sustainability in biomanufacturing processes. As regulatory frameworks evolve, companies are increasingly seeking solutions that not only meet compliance standards but also enhance productivity. The insights gathered from this event will be crucial for professionals in regulatory, QA/QC, CMC, and sourcing roles as they navigate the complexities of the current biopharma environment.
Get started today with Solo access →
